Real-World Data: Sponsors Should Ensure US FDA Access To Patient-Level Data Upon Submission

 
• By Sue Sutter
  
Cherries
FDA BIMO inspectors want to make sure sponsors aren't cherry-picking favorable real-world data. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Real-World Evidence

More from Clinical Trials